Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Therapy
-
-
CompaniesPfizer
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…
-
CompaniesPfizer
Topical Combo based on Pfizer and Novartis Drugs advances after Clearing early Clinical test
by adminby adminSynopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…
-
Summary : First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease Clinical improvements were seen as early as…
-
Summary : Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor…
-
AgrochemicalsGlobal Market
Stopping dementia at the nose with combination of rifampicin and resveratrol
by adminby adminSynopsis : Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A…
-
AgrochemicalsSanofi Inc.
Sanofi’s Isatuximab Added to RVd Boosts Response in Multiple Myeloma
by adminby adminSummary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…
-
AstraZenecaPharma Science & Research
France HAS Approves AstraZeneca’s Evusheld for High-Risk Covid Cases
by adminby adminSummary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…
-
Agrochemicals
The USFDA Grants Orphan Drug Designation to CT120 a Novel CAR T-Cell Therapy of IASO Biotherapeutics for Acute Lymphoblastic Leukemia
by adminby adminKEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…